Standout Papers

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberou... 2012 2026 2016 2021 567
  1. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial (2012)
    David Neal Franz, Е. Д. Белоусова et al. The Lancet

Immediate Impact

15 from Science/Nature 65 standout
Sub-graph 1 of 22

Citing Papers

Fluorescent Probes for Disease Diagnosis
2024 Standout
Single-cell brain organoid screening identifies developmental defects in autism
2023 StandoutNature
2 intermediate papers

Works of E. Martina Bebin being referenced

Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study
2014

Author Peers

Author Last Decade Papers Cites
E. Martina Bebin 905 788 635 49 2.6k
Arto Mannermaa 1098 864 164 72 3.1k
Jonathan Sporn 276 488 424 56 2.8k
Zsuzsanna Nagy 1588 741 319 90 3.7k
Johan Lundkvist 816 228 252 51 3.4k
Margaret L. Ramnaraine 883 207 170 38 2.0k
Patrice Verpillat 613 321 273 72 2.0k
Almut Grenz 343 340 164 50 3.6k
Ralph Zitnik 469 231 129 50 4.1k
Mark T. Brown 457 213 1141 55 2.7k
Salvatore Terrazzino 315 604 152 79 2.3k

All Works

Loading papers...

Rankless by CCL
2026